Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 35: 840-843, 1989;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Rijn, J. L.
Right arrow Articles by Rutten, W. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Rijn, J. L.
Right arrow Articles by Rutten, W. P.

Clinical Chemistry, Vol 35, 840-843, Copyright © 1989 by American Association for Clinical Chemistry

Correction of instrument- and reagent-based differences in determination of the International Normalized Ratio (INR) for monitoring anticoagulant therapy

JL van Rijn, NA Schmidt and WP Rutten
Stichting Medische Laboratoria, Breda, The Netherlands.

As recommended by the World Health Organization, standardization of prothrombin time assays involves conversion of prothrombin times into International Normalized Ratios (INR). We investigated the effect of two different methods (Nycomed's Thrombotest, and Instrumentation Laboratory's PT-fibrinogen) and three coagulation instruments (Schnitger & Gross, KC-10, and ACL) on calculations of INR. The INR plots showed considerable scatter of individual values around the regression lines when the two different methods were compared. Systematic differences in the outcome of INR calculation were related to the use of the different coagulation instruments. Prothrombin times obtained with the different instruments were linearly correlated. We used the bias of these lines to correct results for both the patients' samples and the reference samples. This correction yielded INR values from the different instruments that agreed well.


The following articles in journals at HighWire Press have cited this article:


Home page
 The Annals of PharmacotherapyHome page
D. A Garcia, D. M Witt, E. Hylek, A. K Wittkowsky, E. A Nutescu, A. Jacobson, S. Moll, G. J Merli, M. Crowther, L. Earl, et al.
Delivery of Optimized Anticoagulant Therapy: Consensus Statement from the Anticoagulation Forum
Ann. Pharmacother., July 1, 2008; 42(7): 979 - 988.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
J. Horsti, H. Uppa, and J. A Vilpo
Poor Agreement among Prothrombin Time International Normalized Ratio Methods: Comparison of Seven Commercial Reagents
Clin. Chem., March 1, 2005; 51(3): 553 - 560.
[Abstract] [Full Text] [PDF]

Home page
 J Am Coll CardiolHome page
J. Hirsh, V. Fuster, J. Ansell, and J. L. Halperin
American Heart Association/American College of Cardiology Foundation guide to warfarin therapy
J. Am. Coll. Cardiol., May 7, 2003; 41(9): 1633 - 1652.
[Full Text] [PDF]

Home page
 CirculationHome page
J. Hirsh, V. Fuster, J. Ansell, and J. L. Halperin
American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy
Circulation, April 1, 2003; 107(12): 1692 - 1711.
[Full Text] [PDF]

Home page
 ChestHome page
J. Hirsh, J. E. Dalen, D. R. Anderson, L. Poller, H. Bussey, J. Ansell, and D. Deykin
Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range
Chest, January 1, 2001; 119(1_suppl): 8S - 21S.
[Full Text] [PDF]

Home page
 CLIN APPL THROMB HEMOSTHome page
L. L. Schmitz, S. L. Olson, R. S. Shapiro, S. R. McCormick, and V. L. Kubic
Failure to Generate Comparable International Normalized Ratio Values Using Five Different Thromboplastin Reagents in Parallel Studies of Patients Receiving Warfarin
Clinical and Applied Thrombosis/Hemostasis, March 1, 1995; 1(2): 142 - 150.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1989 by the American Association for Clinical Chemistry.